CAS 942123-43-5

Inarigivir soproxil

CAS: 942123-43-5

Inarigivir soproxil (SB9200) boosts innate immunity, combats HCV 1a/1b (EC50: 2.2/1.0 μM).

Formel: C₂₅H₃₄N₇O₁₃PS

Reinheit: 98.35%

Farbe und Form: Solid

Molekulargewicht: 703.62

Ref: TM-T15573

Inarigivir soproxil

CAS: 942123-43-5

Formel: C₂₅H₃₄N₇O₁₃PS

Reinheit: %

Molekulargewicht: 703.6153

Ref: IN-DA01EOSX

Inarigivir soproxil

CAS: 942123-43-5

Inarigivir soproxil

Reinheit: ≥98%

Molekulargewicht: 703.62g/mol

Ref: 54-BUP04257

Inarigivir Soproxil

Kontrolliertes Produkt

CAS: 942123-43-5

Formel: C₂₅H₃₄N₇O₁₃PS

Farbe und Form: Neat

Molekulargewicht: 703.615

Ref: TR-I627015

Inarigivir Soproxil

CAS: 942123-43-5

Inarigivir Soproxil is a viral replication inhibitor that targets the nucleocapsid protein of the virus. The drug inhibits viral replication by binding to the RNA strand, which blocks the synthesis of viral proteins and thus prevents the virus from reproducing. This drug binds to the viral RNA strand, preventing it from being translated into proteins. Inarigivir Soproxil has been shown to be effective against hepatitis A, B, and C viruses as well as HIV-1 strains that do not have a protease mutation. It has also shown efficacy in treating hepatitis C virus (HCV) infection in patients who are co-infected with HIV-1.

Formel: C₂₅H₃₄N₇O₁₃PS

Reinheit: Min. 95%

Molekulargewicht: 703.62 g/mol

Ref: 3D-SMB12343